BioNovo, Inc. (fka BNVIQ)

[Investox]

BioNovo News


Blockbuster Potential

Article Date: 2012-03-22 11:22:08 AM
Five three-phase attention as a promising new drug candidates
Menopause and High Cholesterol drug side effects, including reduced

Reduce the side effects of conventional treatment of familial hypercholesterolemia and treatment of menopausal symptoms, such as three-phase drug candidates has been noted as a prospect.



In addition, Thomson Reuters in the world during the last quarter phase III trial of new drug candidates entered the Pseudomonas aeruginosa infections, allergies, gout cure was chosen primarily expected 5.



First, bio-Novo (Bionovo) treatment of menopausal hot flashes and night sweats Jane meneoba '(Menerba) an oral plant-derived estrogen receptor beta agonist in the risk of breast and cervical cancer as an alternative to hormone replacement therapy is expected.



That activation of estrogen receptor alpha to increase the risk of cancer of the breast tissue, but the activation of receptor beta to inhibit the growth is affected. In previous clinical studies hormone therapy and the effect was similar but safety.